Figure 2.
Immunofluorescence of deposition in the control and treatment (cisplatin, Bev-high and Bev-low) groups. A: IgG deposition; B: IgM deposition; C: IgA deposition.
Immunofluorescence of deposition in the control and treatment (cisplatin, Bev-high and Bev-low) groups. A: IgG deposition; B: IgM deposition; C: IgA deposition.